List of Excipients in API pindolol
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing pindolol
Detailed excipient profiles for pindolol
Excipient focus: ANHYDROUS LACTOSE
pindolol drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | pindolol | 57664-655 |
| PD-Rx Pharmaceuticals Inc | pindolol | 72789-293 |
| PD-Rx Pharmaceuticals Inc | pindolol | 72789-294 |
| >Company | >Ingredient | >NDC |
pindolol drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
pindolol drug variants containing CELLULOSE, MICROCRYSTALLINE
pindolol drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | pindolol | 62559-560 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
pindolol drug variants containing CROSCARMELLOSE SODIUM
pindolol drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | pindolol | 10135-743 |
| Nostrum Laboratories Inc | pindolol | 29033-028 |
| Sun Pharmaceutical Industries Inc | pindolol | 57664-655 |
| ANI Pharmaceuticals Inc | pindolol | 62559-560 |
| PD-Rx Pharmaceuticals Inc | pindolol | 72789-293 |
| PD-Rx Pharmaceuticals Inc | pindolol | 72789-294 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
pindolol drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | pindolol | 57664-655 |
| PD-Rx Pharmaceuticals Inc | pindolol | 72789-293 |
| PD-Rx Pharmaceuticals Inc | pindolol | 72789-294 |
| >Company | >Ingredient | >NDC |
pindolol drug variants not containing CROSPOVIDONE
Excipient focus: LACTOSE MONOHYDRATE
pindolol drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Nostrum Laboratories Inc | pindolol | 29033-028 |
| >Company | >Ingredient | >NDC |
pindolol drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
pindolol drug variants containing MAGNESIUM STEARATE
pindolol drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
pindolol drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | pindolol | 62559-560 |
| >Company | >Ingredient | >NDC |
pindolol drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: SILICON DIOXIDE
pindolol drug variants containing SILICON DIOXIDE
pindolol drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | pindolol | 57664-655 |
| PD-Rx Pharmaceuticals Inc | pindolol | 72789-293 |
| PD-Rx Pharmaceuticals Inc | pindolol | 72789-294 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
pindolol drug variants containing SODIUM LAURYL SULFATE
pindolol drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | pindolol | 10135-743 |
| Nostrum Laboratories Inc | pindolol | 29033-028 |
| Sun Pharmaceutical Industries Inc | pindolol | 57664-655 |
| ANI Pharmaceuticals Inc | pindolol | 62559-560 |
| PD-Rx Pharmaceuticals Inc | pindolol | 72789-293 |
| PD-Rx Pharmaceuticals Inc | pindolol | 72789-294 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN
pindolol drug variants containing SODIUM STARCH GLYCOLATE TYPE A CORN
| Company | Ingredient | NDC |
|---|---|---|
| Nostrum Laboratories Inc | pindolol | 29033-028 |
| >Company | >Ingredient | >NDC |
pindolol drug variants not containing SODIUM STARCH GLYCOLATE TYPE A CORN
Excipient focus: STARCH, CORN
pindolol drug variants containing STARCH, CORN
pindolol drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
